Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 205,502,960
  • Shares Outstanding, K 1,739,634
  • Annual Sales, $ 40,109 M
  • Annual Income, $ 5,723 M
  • 60-Month Beta 0.72
  • Price/Sales 5.10
  • Price/Cash Flow 18.30
  • Price/Book 5.12
Trade ABT with:

Options Overview Details

View History
  • Implied Volatility 23.11% ( +0.88%)
  • Historical Volatility 14.62%
  • IV Percentile 77%
  • IV Rank 47.82%
  • IV High 32.46% on 10/12/23
  • IV Low 14.54% on 05/17/24
  • Put/Call Vol Ratio 0.76
  • Today's Volume 7,876
  • Volume Avg (30-Day) 12,147
  • Put/Call OI Ratio 1.13
  • Today's Open Interest 218,362
  • Open Int (30-Day) 203,335

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 1.20
  • Number of Estimates 8
  • High Estimate 1.22
  • Low Estimate 1.18
  • Prior Year 1.14
  • Growth Rate Est. (year over year) +5.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
110.33 +4.12%
on 08/20/24
118.54 -3.09%
on 09/17/24
+3.88 (+3.50%)
since 08/16/24
3-Month
99.71 +15.21%
on 07/18/24
118.54 -3.09%
on 09/17/24
+10.89 (+10.47%)
since 06/18/24
52-Week
89.67 +28.11%
on 10/12/23
121.64 -5.56%
on 03/08/24
+13.88 (+13.74%)
since 09/18/23

Most Recent Stories

More News
Can AbbVie Regain Its Status As a Top Dividend Growth Stock?

The dividend growth powerhouse is turning the corner.

ABT : 114.88 (-2.75%)
ABBV : 192.94 (-0.26%)
Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy?

The company continues to flex its innovative muscles.

ABT : 114.88 (-2.75%)
3 Stocks to Buy and Hold Forever

These stocks are built for the long run.

ABT : 114.88 (-2.75%)
ABBV : 192.94 (-0.26%)
LLY : 904.97 (-0.13%)
VRTX : 474.16 (-1.48%)
Roche Stock to Benefit From Accu-Chek Smartguide Launch in Europe

Roche RHHBY is set to enter the competitive continuous glucose monitor (CGM) market in Europe following the CE mark approval of its Accu-Chek Smartguide in July.The Swiss pharmaceutical company plans to...

ABT : 114.88 (-2.75%)
RHHBY : 39.5100 (+0.46%)
ISRG : 482.09 (-0.25%)
DXCM : 69.46 (+0.75%)
3 Ultra-Safe Dividend Stocks for Retirees to Buy and Hold

These stocks have increased their payouts for decades.

ABT : 114.88 (-2.75%)
PG : 173.92 (-1.11%)
ENB : 40.52 (-0.73%)
Medtronic Keeps Capturing High-Growth Markets: Time to Buy MDT Stock?

The past month has been quite encouraging for Medtronic MDT investors. Solid first-quarter fiscal 2025 organic growth performance and several strategic initiatives to revamp the bottom line, including...

ABT : 114.88 (-2.75%)
BSX : 82.57 (+0.06%)
BDX : 231.59 (+0.14%)
MDT : 88.13 (-0.56%)
2 Stocks That Are Passive Income Machines to Buy and Hold Forever

You can take these dividends straight to the bank.

ABT : 114.88 (-2.75%)
JNJ : 166.15 (-0.55%)
3 Recession-Proof Dividend Kings to Buy For a Lifetime of Income

Discover three proven, quality companies you can own to get through a looming recession.

TGT : 153.60 (+1.08%)
SYY : 74.54 (-4.17%)
ABT : 114.88 (-2.75%)
Is Abbott Stock Underperforming the S&P 500?

Abbott's shares have underperformed the broader S&P 500 this year, but analysts are highly bullish on the stock's potential.

ABT : 114.88 (-2.75%)
$SPX : 5,618.26 (-0.29%)
MDT : 88.13 (-0.56%)
3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever

These three have secure core businesses, plus multiple paths to grow.

ABT : 114.88 (-2.75%)
ABBV : 192.94 (-0.26%)
VRTX : 474.16 (-1.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 119.73
2nd Resistance Point 118.62
1st Resistance Point 116.75
Last Price 114.88
1st Support Level 113.76
2nd Support Level 112.65
3rd Support Level 110.78

See More

52-Week High 121.64
Last Price 114.88
Fibonacci 61.8% 109.43
Fibonacci 50% 105.66
Fibonacci 38.2% 101.89
52-Week Low 89.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar